SEC Tracker
Get the app

Celcuity CELC

Celcuity FY 2022: net loss $40.4M; diluted EPS −$2.64

Form
10-K/A
Filed
Period
Importance
Routine
Document
10-K/A

Key figures from this report

These are the numbers Celcuity reported for the year ended Dec 31, 2022, as tagged in the filing’s XBRL data, each against the year before. A plain-English reading of this report is not written yet.

  1. Net income−$40.4MAgainst −$29.6M in FY 202110-K income statement, on EDGAR
  2. Diluted EPS−$2.64No year-earlier figure tagged10-K income statement, on EDGAR
  3. Cash and cash equivalents$24.6M−71% from $84.3M in FY 2021Cash and equivalents only; the company page adds short-term investments.10-K balance sheet, on EDGAR
  4. Cash from operations−$36.0MAgainst −$20.3M in FY 202110-K cash flow statement, on EDGAR

Every year in the financial tables

View on EDGAR

Open in the app

Get an email when Celcuity files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 8071 and related industry codes: the same peer list as the financial tables.

  1. Fortrea Holdings FTRE public float $448M, Jun 30, 2025
  2. Castle Biosciences CSTL public float $576M, Jun 30, 2025
  3. Personalis PSNL public float $578M, Jun 30, 2025
  4. Fulgent Genetics FLGT public float $284M, Jun 30, 2025
  5. CareDx CDNA public float $1.0B, Jun 30, 2025